Uma publicação bimestral que faz parte do portfólio de periódicos da Sociedade Brasileira de Cardiologia relacionados à ABC Cardiol e que publica produção científica nacional e internacional no campo das ciências cardiovasculares.
Uma publicação bimestral que faz parte do portfólio de periódicos da Sociedade Brasileira de Cardiologia relacionados à ABC Cardiol e que publica produção científica nacional e internacional no campo das ciências cardiovasculares.
Ischemic heart failure is a growing disease with high morbidity and mortality. Several studies suggest the benefit of viability imaging to assist revascularization decision, but there is controversy. Multiple imaging modalities can be used to accurately define hibernating myocardium; however, the best approach remains uncertain. This review will highlight current evidence and future directions of viability imaging assessment.
Myocardial Viability: From PARR-2 to IMAGE HF – Current Evidence and
Future Directions
ErthalF, WiefelsC, PromislowS, KandolinR, StadnickE, MielniczukL, RuddyT, et al. Myocardial Viability: From PARR-2 to IMAGE HF – Current Evidence and
Future Directions. Int. J. Cardiovasc.
Sci. 2019;32(1):70-83.
Erthal,Fernanda; Wiefels,Christiane; Promislow,Steven; Kandolin,Riina; Stadnick,Ellamae; Mielniczuk,Lisa; Ruddy,Terrence; Small,Gary; Beanlands,Rob. Myocardial Viability: From PARR-2 to IMAGE HF – Current Evidence and
Future Directions. Int. J. Cardiovasc.
Sci., v. 32, n. 1, p. 70-83, jan. 2019.
Erthal,F., Wiefels,C., Promislow,S., Kandolin,R., Stadnick,E., Mielniczuk,L., Ruddy,T., Small,G., & Beanlands,R. (2019). Myocardial Viability: From PARR-2 to IMAGE HF – Current Evidence and
Future Directions. Int. J. Cardiovasc.
Sci.,32(1), 70-83.
Erthal,Fernanda and Wiefels,Christiane and Promislow,Steven and Kandolin,Riina and Stadnick,Ellamae and Mielniczuk,Lisa and Ruddy,Terrence and Small,Gary and Beanlands,Rob. Myocardial Viability: From PARR-2 to IMAGE HF – Current Evidence and
Future Directions. Int. J. Cardiovasc.
Sci. [online]. 2019, vol. 32, n. 1, [cited 2025-09-06], pp.70-83. Available from: <https://ijcscardiol.org/pt-br/article/myocardial-viability-from-parr-2-to-image-hf-current-evidence-andfuture-directions/>. ISSN 2359-4802.
Figure 1
"Images illustrating different combinations of FDG uptake and LGE
transmurality. First column: FDG ≥ 50%/LGE nontransmural ('PET
viable/MRI viable); second column: FDG < 50%/LGE transmural ('PET
non-viable/MRI non-viable'); third column: FDG < 50%/LGE
non-transmural ('PET non-viable/MRI viable'). White arrows indicate the
respective area of ischaemically affected myocardium." – With permission
from Rischpler et al, Eur Heart J Cardiovasc Imaging.30